Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 8/20 | 0.51 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.51 |
| ▸ | ACE | P12821 | 2/20 | 0.50 |
| ▸ | CTSC | P53634 | 1/20 | 0.50 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.49 |
| ▸ | ECE1 | P42892 | 1/20 | 0.49 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.48 |
| ▸ | GHSR | Q92847 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30093039 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL29732261 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL30302924 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL30093103 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL30339793 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL30093123 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL30302936 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL29799990 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL30798752 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 | |
| SCHEMBL30305362 | 1.00 | IL23R (0.51) | IL23RKISS1RACECTSCMAGI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320266-A1 | Methods and Compositions for Treatment of Antibiotic-Resistant Bacterial Infections | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2025-10-16 | — | — | US | disclosed |
| US-12371463-B2 | Methods and compositions for treatment of antibiotic-resistant bacterial infections | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2025-07-29 | — | — | US | disclosed |
| CN-118265536-A | Engineered antibacterial peptides and uses thereof | 肽逻辑公司 | 2024-06-28 | — | — | CN | disclosed |
| WO-2023044487-A1 | TREATMENT OF LUNG DISEASE OR INJURY USING ENGINEERED ANTIMICROBIAL PEPTIDES | PEPTILOGICS, INC. (US) | 2023-03-23 | — | — | WO | disclosed |
| US-20220332777-A1 | Methods and Compositions for Treatment of Antibiotic-Resistant Bacterial Infections | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2022-10-20 | — | — | US | disclosed |
| WO-2022173981-A1 | INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES | PEPTILOGICS, INC. (US) | 2022-08-18 | — | — | WO | disclosed |